Clinical Trial Update: MSM Product on Attenuating Nasal Provocation With a Standardized Allergenic Challenge [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial assessing an MSM product for attenuating nasal provocation with a standardized allergen challenge in aller…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• MSM (methylsulfonylmethane)

Snippet

Sponsor: Medicus Research, LLC | Conditions: Nasal Breathing | Phase 2 | Status: COMPLETED